Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Carroll

Showing results (951-960 of 963) with videos related to

Pageof 97
Sort By:
JAMA Internal Medicine|July 22, 2020
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020Fiona P Havers, Carrie Reed, Travis Lim, et al.
Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.
Journal of the National Cancer Institute|December 15, 2015
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic TargetMohammad Asim, Charles E Massie, Folake Orafidiya, et al.
Nature Communications|February 7, 2024
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97Amir Pozner, Li Li, Shiv Prakash Verma, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
Plos Biology|September 24, 2024
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resistJérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97Amir Pozner, Shiv Prakash Verma, Li Li, et al.
Genome Research|February 9, 2008
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targetsDavid S Johnson, Wei Li, D Benjamin Gordon, et al.
Nature|November 30, 2022
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancerAndrew L H Webster, Mathijs A Sanders, Krupa Patel, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 97

Showing results (951-960 of 963) with videos related to

Sort By:
Pageof 97
JAMA Internal Medicine|July 22, 2020
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020Fiona P Havers, Carrie Reed, Travis Lim, et al.
Nature|January 7, 2016
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Charles Y Lin, Housheng Hansen He, et al.
Journal of the National Cancer Institute|December 15, 2015
Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic TargetMohammad Asim, Charles E Massie, Folake Orafidiya, et al.
Nature Communications|February 7, 2024
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97Amir Pozner, Li Li, Shiv Prakash Verma, et al.
ACS Medicinal Chemistry Letters|July 21, 2016
Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding GroupChristopher J Bungard, Peter D Williams, Jeanine E Ballard, et al.
Plos Biology|September 24, 2024
A genome-wide arrayed CRISPR screen identifies PLSCR1 as an intrinsic barrier to SARS-CoV-2 entry that recent virus variants have evolved to resistJérémie Le Pen, Gabrielle Paniccia, Volker Kinast, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
ASPSCR1-TFE3 reprograms transcription by organizing enhancer loops around hexameric VCP/p97Amir Pozner, Shiv Prakash Verma, Li Li, et al.
Genome Research|February 9, 2008
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targetsDavid S Johnson, Wei Li, D Benjamin Gordon, et al.
Nature|November 30, 2022
Genomic signature of Fanconi anaemia DNA repair pathway deficiency in cancerAndrew L H Webster, Mathijs A Sanders, Krupa Patel, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 97